[Global Network Reporter Suo Yanqi] According to Reuters, Ebole, chairman and CEO of US pharmaceutical giant Pfizer, said at an event of the National Committee on U.S. -China Relations on Tuesday (14th) local time that the US pharmaceutical industry needs Cooperation with China.

¡°In the biopharmaceutical sector, China has triggered a shift in the global competitive pattern at an astonishing rate, cost (control) and scale,¡± said Abel.

Reuters mentioned that Albert made the above remarks at a time when the trade relationship between the United States and China was tense. Despite this, pharmaceutical companies in the United States and Europe have also been looking to China to supplement their drug research and development lines, the media said.

The U.S. government's new round of tariff increases will take effect one after another on October 1, covering many fields such as medicines, timber, and heavy trucks. Among them, tariffs of up to 100% may be imposed on all imported brand or patented drugs.

However, the idea that the U.S. government relies on tariff increases to promote the "reshoring" of manufacturing seems unrealistic. Take the pharmaceutical industry involved in the new round of tariff increase as an example. The U.S. government previously asked pharmaceutical manufacturers to sell at low prices to American consumers and build factories in the United States, with the intention of imposing tariffs to coerce the pharmaceutical industry to "return". However, people in the industry generally say that it is too early to talk about "backflow". On the one hand, unclear policies have kept many pharmaceutical companies on the sidelines. On the other hand, the decision to impose tariffs on drugs was too hasty. In addition, tariff increases are pushing up domestic inflation in the United States, which has become the consensus of mainstream public opinion and research institutions in the United States. Industry insiders are worried that the cost pressure generated by the new round of tariffs may be further transmitted to American consumers.